MedTrace Logo

Secondary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health (S-PLAC 2)

NCT04118673 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2025-03-25

No results posted yet for this study

Summary

Prescribing lifestyle changes to patients who have cardiovascular disease (CVD) may be an extremely cost effective mechanism of improving health individually and for the NHS. Positive lifestyle changes such as improved diet, increased physical activity, quitting smoking and reducing alcohol consumption have been proven to reform the health status of individuals with CVD. S-PLAC 2 is a phase II study to determine the efficacy of a lifestyle prescription (L℞) in patients and healthcare practitioners in a secondary care setting (i.e. hospital clinics/wards).

Conditions

Interventions

BEHAVIORAL

Lifestyle Prescription (LRx)

Standard care during consultations with the addition of a physical lifestyle prescription

Sponsors & Collaborators

  • Public Health Wales

    collaborator OTHER_GOV

  • Cwm Taf University Health Board

    collaborator UNKNOWN

  • University of South Wales

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-07
Primary Completion
2021-03-31
Completion
2023-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04118673 on ClinicalTrials.gov